Dr. Bryon D. Quick, MD
Critical Care Medicine (Critical Care Medicine (Internal Medicine) Physician)
At a glance
- Medical school
- Rutgers School of Dental Medicine (1994)
- Years since graduation
- 32
- In the NPI registry since
- 2006
Licensed in California since 2000, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1994Medical school: Rutgers School of Dental Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Critical Care Medicine (Internal Medicine) Physician primary
CA license G85792 (first issued 2000; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Kaiser Foundation Hospital - Oakland/richmond Oakland, CA
Medical groups
- Permanente Medical Group Inc (10,996 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trikafta (elexacaftor/tezacaftor/ivacaft) | 75 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Oakland, CA | 54 |
| Wixela Inhub (fluticasone propion/salmeterol) Other prescribers in Oakland, CA | 36 |
| Spiriva Respimat (tiotropium bromide) Other prescribers in Oakland, CA | 23 |
| Stiolto Respimat (tiotropium br/olodaterol hcl) Other prescribers in Oakland, CA | 19 |
| Zenpep (lipase/protease/amylase) Other prescribers in Oakland, CA | 19 |
| Azithromycin Other prescribers in Oakland, CA | 18 |
| Prednisone Other prescribers in Oakland, CA | 15 |
| Cayston (aztreonam lysine) | 14 |
| Symdeko (tezacaftor/ivacaftor) | 14 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $35.57 in total to this clinician.
| Pulmonx Corporation | $19.57 |
|---|---|
| Intuitive Surgical, Inc. | $16.00 |
| Food and Beverage | $35.57 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $41,193 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
Vertex Pharmaceuticals Incorporated
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.